SCHEMBL76294

SCHEMBL76294

c1ccc(-c2cccc(-c3ccccc3)c2O[Al](Oc2c(-c3ccccc3)cccc2-c2ccccc2)Oc2c(-c3ccccc3)cccc2-c2ccccc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPK1 P28482 2/20 0.41
HPGD P15428 1/20 0.41
BCL2L1 Q07817 1/20 0.41
CYP2A6 P11509 1/20 0.41
BACE1 P56817 1/20 0.37
DPP4 P27487 1/20 0.37
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
HNF4A P41235 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
HDAC4 P56524 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL396393 0.82 PDCD1 (0.38) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL395171 0.82 PDCD1 (0.38) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL3243159 0.80 SLC6A4 (0.40) CLK4MAPK9MAP4K4CSF1RFGFR1
SCHEMBL3240740 0.79 METAP2 (0.41) ALDH1A1MAPK1CYP2A6BACE1METAP2
SCHEMBL854412 0.77 ALDH1A1 (0.46) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL7741488 0.77 PDCD1 (0.39) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL3698066 0.77 PDCD1 (0.39) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL16738296 0.76 MAPK1 (0.47) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL13385087 0.73 PDE4B (0.48) ALDH1A1HSD17B10MAPK1HPGDBCL2L1
SCHEMBL22981733 0.73 ALDH1A1 (0.42) ALDH1A1HSD17B10MAPK1HPGDBCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 316 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600940-B2 Strains and processes for single cell protein or biomass production Solar Foods Oyj (FI) 2026-04-14 US claimed
US-12467057-B2 Methods for modifying plastid genomes MONSANTO TECHNOLOGY LLC (US) 2025-11-11 US claimed
CN-118326067-B Identifying gynostemma pentaphylla and peduncles method and application of gynostemma pentaphylla 中国医学科学院药用植物研究所 2025-04-18 CN claimed
CN-119661324-A Preparation method of high-content cis-isophorone 宿迁科思化学有限公司 2025-03-21 CN claimed
EP-4476372-A1 HYDROMETALLURGICAL PROCESS FOR THE SELECTIVE RECOVERY OF VANADIUM, MOLYBDENUM AND OTHER BASE METALS FROM VARIOUS TYPES OF INDUSTRIAL WASTE Orim S.r.l. (IT) 2024-12-18 EP claimed
US-20240368529-A1 A STRAIN OF CHLORELLA SOROKINIANA ALIGA APS (DK) 2024-11-07 US claimed
CN-118326067-A Method for identifying gynostemma pentaphylla and application 中国医学科学院药用植物研究所 2024-07-12 CN claimed
EP-4369949-A2 A STRAIN OF CHLORELLA SOROKINIANA Aliga ApS (DK) 2024-05-22 EP claimed
US-20240093141-A1 STRAINS AND PROCESSES FOR SINGLE CELL PROTEIN OR BIOMASS PRODUCTION SOLAR FOODS OY (FI) 2024-03-21 US claimed
US-20230406911-A1 COMPOSITIONS AND METHODS FOR PREVENTING, INHIBITING, DISRUPTING, OR TREATING A POLYMICROBIAL BIOFILM RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (US) 2023-12-21 US claimed
CN-115125328-A DNA bar code for identifying swertia plants and application thereof 青海师范大学 2022-09-30 CN claimed
CN-114599779-A Strains and methods for single cell protein or biomass production 太阳食物有限公司 2022-06-07 CN claimed
WO-2022094433-A2 COMPOSITIONS AND METHODS FOR PREVENTING, INHIBITING, DISRUPTING, OR TREATING A POLYMICROBIAL BIOFILM RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL (US) 2022-05-05 WO claimed
WO-2022055750-A1 PLASTID TRANSFORMATION BY COMPLEMENTATION OF PLASTID MUTATIONS PLASTOMICS INC. (US) 2022-03-17 WO claimed
US-6878789-B2 Preparation process of acrylic acid ester polymer KURARAY CO., LTD. (JP) 2005-04-12 US claimed
US-6831144-B2 Containing, in addition to an anionic polymerization initiator, a organoaluminum compound containing aryloxy groups, a Lewis base, and an ether or a tertiary amine KURARAY CO., LTD. (JP) 2004-12-14 US claimed
EP-0945470-B1 Preparation process of acrylic acid ester polymer KURARAY CO (JP) 2004-10-13 EP claimed
US-20020032290-A1 Preparation process of acrylic acid ester polymer KURARAY CO., LTD. (JP) 2002-03-14 US claimed
US-6329480-B1 POLYMERIZING ACRYLIC ACID ESTER, ACRYLIC/METHACRYLIC MONOMER PRESENCE OF AN ORGANOLITHIUM COMPOUND AND AN ORGANOALUMINUM COMPOUND TO FORM BLOCK COPOLYMER KURARAY CO., LTD. (JP) 2001-12-11 US claimed
EP-0945470-A1 Preparation process of acrylic acid ester polymer KURARAY CO., LTD. (JP) 1999-09-29 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12600940-B2 Strains and processes for single cell protein or biomass production XDH, VAT1, FNTB ALDH1A1 2350/4885HSD17B10 739/4885MAPK1 2755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.